"Classmate, do you want to become the CEO?" what Yang Fan said before actually had the same meaning as this sentence.

The people around looked at Xia Shuyu's gaze and were a little stunned for a while.

Xia Shuyu's talent so far has been valued by many people.

But in the final analysis, the process of Xia Shuyu's development is a small and broad process.

Because in a short period of time, the capital has increased several times, so Xia Shuyu has been noticed by people.

But in fact, the scale of Xia Shuyu's previous company was still a bit small.

Such a small company, even if it is a small Boda to win several times the increase, in the final analysis, the total turnover will not make the real big names in these circles entangled.

It is precisely because of this that Xia Shuyu has not had time to be really poached by those listed companies.

In the final analysis, not all listed companies are well mixed. If Xia Shuyu's talent really reached a more unnatural level, Xia Shuyu was afraid that she would have been approached by some listed companies in poor condition and sought a way out for the company.

Xia Shuyu really doesn't rely on her looks to eat. Obviously, you can rely on your face to eat, but you have to rely on your talent.

In fact, Xia Shuyu's appearance still gave her a certain amount of extra points.

Among the younger generation, there are still a few talents with similar performance to Xia Shuyu. But Xia Shuyu has received the most attention, because of Xia Shuyu's positioning as a "good match for the second ancestor".

Although Xia Shuyu's current fame is indeed not small, in fact, the scale of the company she worked for before was actually limited. Not to mention the world's top hundreds, there is still a distance from being listed.

In the final analysis, listed companies are not necessarily very lofty. The total share capital of the company is not less than 30 million yuan, which is one of the basic requirements.

It is not that the company's assets are enough for 30 million yuan to be listed.

But in the final analysis, only if there is money, as long as it is operated properly, for these real rich people, listed companies are not too high-minded existence.

Speaking of which, within Huaxia, there are also more than 3,000 listed companies.

But even if it is a listed company, it does not mean the highest achievement in the market. Many companies obviously have such ability, but they avoid the method of going public to raise funds.

But for Xia Shuyu's previous circle, it was still too high-end.

Yang Fan is not particularly clear about the scale of Melodious Pharmaceutical. But in fact, Melodious Pharmaceutical is definitely the most promising pharmaceutical production company in recent years.

Before Yang Fan appeared, the drug market within Huaxia had generally stabilized.

In fact, it is just like when Yang Tianyi and the entire Jiangbei medical immortal family fought against each other. It is the current Jiangbei medical immortal family, although it can represent the cutting-edge medical skills of the Chinese medical community, but it is not so self-respecting.

The prescriptions taken out by the Jiangbei Medical Immortal Family must still be very good. But from head to toe, the high, medium and low-end competitors are all crushed in terms of efficacy and cost. Again, it's not that easy.

Jiangbei medical immortal family came up with an ancient prescription, and the Chinese medicine community, many times, is still a master of the Western medicine world, and soon can come up with a treatment policy with similar effect.

In the final analysis, as long as we cannot occupy an absolute advantage in terms of efficacy and cost, it is difficult to form a strong dominance over the drug market with one symptom.

Now, however, Yang Fan has done it. The efficacy of light powder blood exhaustion cream not only surpasses all burn drugs on the market, but also its cost is also down to an outrageous level.

To put it simply, it is only a matter of time before light powder blood exhaustion cream dominates the burn medicine market.

Don't look at burns, it's not too frequent. Many people will not necessarily experience this kind of problem in their lifetime.

That's right, the market for burn medicine is indeed not as huge as the market for drugs such as cold medicine.

However, if monopoly can be almost realized, the benefits actually represented are also considerable.

Besides, who said that Melodious Pharmaceutical will only produce this one drug in the future?

Just a medicine of light powder blood depletion ointment already represents such a great benefit. Since it can come up with light powder blood exhaustion ointment, it proves that the scientific research ability of Melodious Pharmaceutical has actually reached a certain height, and the scientific research ability of Melodious Pharmaceutical should be absolutely sufficient for the subsequent differentiation of the market and even the development of new drugs.

Therefore, inside and outside the circle, the prospect of melodious pharmaceuticals is actually quite optimistic.

The current scale of Melodious Pharmaceutical is actually much larger than the scale of Xia Shuyu's old company. And because of this potential, the industry generally believes that it will not be long before Melodious Pharmaceutical will be able to go on the market.

If the company is not listed, there is a situation of "more than three years of operation", maybe Melodious Pharmaceutical can grow faster.

That's right, you'll have to wait three years.

However, in the eyes of industry insiders, as long as it is not in a short period of time, someone has developed a burn agent that is better than light powder blood exhaustion ointment. The listing of Melodious Pharmaceutical seems to be an unstoppable process.

And in fact, from the current situation. Melodious Pharmaceutical has been at the forefront of the medical community in terms of burn medicines. By the time other companies finally developed the production process of light powder blood exhaustion cream, maybe Melodious Pharmaceutical had already completed the improvement of light powder blood exhaustion cream.

Then, Yang Fan asked Xia Shuyu very easily, do you want to become the CEO of our company?

This is of course a good opportunity for Xia Shuyu, but Xia Shuyu really can't help but be a little stunned.

Doing business is not a playhouse, and many families know that their juniors have average abilities. But I'm still willing to use people from my own family, rather than using senior talents from outside.

To a large extent, it's because I trust my own people more.

The CEO, CFO and other positions of a company are a situation in which they have great management authority over the company's internal management.

The full name of CEO is Chief Executive Officer, which translates to Chief Executive Officer. The day-to-day affairs of the company are generally handed over to the CEO.

CFO stands for Chief Financial Officer, which translates to Chief Financial Officer. To put it simply, it's money-sensitive.

If such a position is given to someone who you can't trust absolutely, what if something happens?

The current situation is that it is such a position, and if you are alone, it is not so simple to completely screw up your company. Within the company, it is a situation where multiple high-end positions check and balance each other. will not be a single person, real absolute decentralization.